Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Julphar
US Army
QuintilesIMS
Argus Health
Cantor Fitzgerald
Medtronic
Baxter
Harvard Business School

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020208

« Back to Dashboard

NDA 020208 describes METROGEL-VAGINAL, which is a drug marketed by Medicis and is included in one NDA. It is available from four suppliers. Additional details are available on the METROGEL-VAGINAL profile page.

The generic ingredient in METROGEL-VAGINAL is metronidazole. There are eighteen drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 020208
Tradename:METROGEL-VAGINAL
Applicant:Medicis
Ingredient:metronidazole
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 020208
Ingredient-typeNitroimidazoles
Medical Subject Heading (MeSH) Categories for 020208
Suppliers and Packaging for NDA: 020208
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208 NDA AUTHORIZED GENERIC Aidarex Pharmaceuticals LLC 33261-786 N 33261-786-01
METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208 NDA Physicians Total Care, Inc. 54868-3110 E 54868-3110-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;VAGINALStrength0.75%
Approval Date:Aug 17, 1992TE:ABRLD:Yes

Expired US Patents for NDA 020208

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
Accenture
US Department of Justice
Mallinckrodt
Harvard Business School
Dow
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.